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Abstract: Alzheimer's diseases is one of the type of dementia. This is one of 
the harmful disease which can lead to death and yet there is no treatment. 
There is no current technique which is 100% accurate for the treatment of 
this disease. In recent years, Neuroimaging combined with machine learning 
techniques have been used for detection of Alzheimer's disease. Based on 
our survey we came across many methods like Convolution Neural Network 
(CNN) where in each brain area is been split into small three dimensional 
patches which acts as input samples for CNN. The other method used was 
Deep Neural Networks (DNN) where the brain MRI images are segmented 
to extract the brain chambers and then features are extracted from the 
segmented area. There are many such methods which can be used for 
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Alzheimer’s Diseases (AD) is the most frequent shape of dementia, which is an innovative talent 
ailment by and large happening in the late life. Comparing with the patient’s preceding functions, a 
decline in reminiscence and different cognitive features is referred to as a major dementia syndrome. 
There are three different types of AD: preclinical, Mild Cognitive Impairment and Dementia. 
Preclinical ability early onset of Alzheimer’s and so occurs to these youthful and under sixty five 
years. It's an uncommon case in scientific records with 5% of human beings catching these early 
onsets of Alzheimer’s. Mild Cognitive Impairment (MCI) is a transitional stage [1]. 
This is related with language, thinking, reminiscence adjustments and judgment higher than the 
everyday condition. Finally, dementia is major category of brain diseases. The early stage of dementia 
will have some frequent symptoms. It has lengthy time period impact on linguistic capacity and it will 
undergo upon every day functioning in a person’s lifetime.Dementia will reason one-of-a-kind 
conditions, which consist of Huntington’s disease, Creutzfeldt-Jakob sickness (CJD), Lewy body 
disease and vascular dementia, Parkinson’s disease, and Wernicke-Korsakoff syndrome [2]. 
Medical imaging performs an imperative function in dementia. Imaging biomarkers are a set of 
indications computed from photograph modalities and can be used for the early detection of AD 
diseases. Some usually used scientific pictures to analysis dementia at an early stage consist of 
magnetic resonance imaging (MRI), positron emission tomography (PET) [3], Cerebro-spinal Fluid 
(CSF), single-photon emission computed tomography (SPECT), Computerized Tomography 
(CTscans), electroence p-halogram(EEG)signal [4] [5]. It assesses the total brain signals. 
Structural MRI makes use of radio waves and a magnetic area to picture tissues and organs in the 
human body. This approach offers many advantages, which include higher smooth tissue contrast, 
decrease cost, higher accessibility and regional atrophy. Structural MRI picture are obtained from 
Alzheimer’s sickness Neuroimaging Initiative (ADNI) for figuring out AD progression. Functional 
PET having some a variety of radioactive tracers, for example, 18CPittsburgh Compound (11C-PiB), 
and 2-[18F] Fluoro-2-deoxy-D-glucose (FDG) can become aware of the moderate adjustments in 
amyloid deposition or cerebral metabolism prior to anatomical modifications is a symptomatological 
diagnosis of dementia. Functional SPECT is analogous to PET pics via the usage of a radioactive 
isotope and imaging gamma rays from it [6]. 
SPECT scan is much less highly-priced than PET scans however decrease spatial decision 
compared to PET scans has. In clinical research, obtaining the data sets is very difficult, that too 
acquiring 3-d dataset photographs is ordinarily unexplored .Comparatively low extent of work is 
absolutely based on visible evaluation of slice by slice search of 3-d datasets for affected illnesses 
patterns.This will require sizeable knowledge, effort, fee and time. Inasmuch as the doctor’s opinion, 
computer aided classification and identification of dementia is nonetheless the most promising device 
at an early stage. Those processes are categorized into three categories: differentiating AD from NC 
figuring out the exclusive levels of AD: MCI from AD and AD from FTD. 
There are many databases reachable for diagnosis of AD, together with the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) [7] and Open Access Series of Imaging Studies (OASIS) [8]. These 
databases are broadly used for identification and classification of dementia an early stage in the 
research. 
 
2. Related Work 
Developing an Alzheimer’s Disease detection and classification model is a pretty challenging task. 
But there are some remarkable research work in this area.  
 
2.1. Convolution Neural Network 
In Jyoti & Zhang [9], Alzheimer’s disease detection and classification is done when the input (T1-
weighted MRI scans from OASIS dataset) is passed through a stem layer. This stem layer includes 
several 3*3 convolution layers, 1*1 convolution layer, and max pooling layer. In the convolution 
layer, there are two types of modules: Inception and Reduction, Inception has three modules and 
Reduction has two modules. The input and output of all these modules pass through various filter 
concatenation process. They have redesigned the final softmax layer for Alzheimer’s disease detection 
and classification. Nondemented, very mild, mild, and moderate AD are the four different output 
classes of the softmax layer. MRI image is taken as input by the network and it extracts layerwise 
feature representation from the first stem layer to the last drop-out layer. Based on this mentioned 
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feature representation, the input MRI image is classified to any of the four output classes. They have 
also applied data augmentation techniques such as reflection and scaling. 
Basaia et.al [10] utilize single MRI and deep neural networks. An independent dataset of 3D T1-
weighted images was obtained from ADNI and Milan. 3D T1- weighted images from both datasets 
were normalized to the MNI space using Statistical Parametric Mapping and the Diffeomorphic 
Anatomical Registration Exponentiated Lie Algebra (DARTEL) registration method. Given the 
volumetric nature of MR images, a network architecture that uses 3D convolutions was developed 
first. Then inputs were normalized 3D T1-weighted images and the outputs to be predicted were 
subject groups. The network used in their study differs from the standard CNNs as max-pooling layers 
were replaced by standard convolutional layers with a stride of 2. 
To improve the performance of the classifier, a transfer learning was applied, i.e., weights of the 
Convolution Neural Network (CNN) used to classify ADNI AD vs HC (healthy controls) were 
transferred to the other CNNs and used as (pre-trained) initial weights. CNN was finally used to 
classify raw images of the testing set available. CNN's performance was evaluated by several 
performance measures such as sensitivity, specificity, and accuracy. 
Hongming & Fan [11] included data from the ADNI (http://adni.loni.usc.edu) and AIBL 
(www.aibl.csiro.au) cohorts, consisting of baseline MRI scans and Hippocampus extraction was done 
to this dataset. These hippocampal data were used to extract features and build the prognostic model a 
deep learning model of convolutional neural networks was used for informative feature extraction. A 
time-to-event prognostic model based on deep imaging features estimates overall risk scores to 
progress to AD dementia for individuals. 
In Pan et al [12] developed a three-axis multi-slice (i.e. sagittal, coronal, and transversal slices) 
MRI classifier using CNN and ensemble learning. In the standard MNI space, the intersection points 
were determined by the most discriminable three-axis slices that were located in some identified brain 
regions with the help of Brainnetome Atlas.  
Chen, et al [13] used five components for Detection of Alzheimer’s Disease from Narrative 
Speech. Firstly, Embedding layer will map each word from the input transcript into a continuous 
vector. Secondly, GRU layer applies bidirectional GRU on the top of the word embedding layer to get 
contextual word representations. Thirdly, CNN layer which performs one-dimensional convolution on 
embedded word sequence to extract local n-gram patterns from transcript. Fourth, Attention layer 
takes the input of the output of the previous layer (feature map from CNN or contextual word 
representations from biGRU) and calculates a weight vector that measures the importance of each 
feature and computes the transcript-level vector as a weighted sum of features. Lastis the Output layer 
which concatenates transcript-level vectors from CNN and GRU branches, and feed the resulting 
vector to a fully-connected layer for softmax classification.  
 
2.2. Deep Neural Network 
In Kajal Kiran Gulhare, et al [14] DNN classification is considered to be a tool for Alzheimer disease 
detection. Minimum error rate is obtained from DNN with three hidden layers and softmax layer as an 
output layer which is superior to that obtained from the SVM and backpropagation classifier. The 
MRI data was accessed and stored in the database and data pre-processing technique was used for 
removing non-relevant information and for better interpretation. The image segmentation methods 
were applied on the image data to extract different features of the data. The attributes were extracted 
from the data and artificial neural network based classification method was applied on extracted data 
to verify feasibility of the classifier. The niblack-thresholding segmentation algorithm was used for 
the segmentation process. 
Thung, et al [15] used multi-task deep learning of incomplete data, where prediction tasks that are 
associated with different modality combinations are used to improve the performance of each task. 
They combined a multi-input multi-output deep learning framework and trained a network by 
updating its weights based on the availability of modality data. ADNI dataset was used and Multi-
Task Deep Learning (MTDL) framework contains two types of input (one for each modality) and 
three types of output (one for each classification task). The architecture consists of three layers, i.e., 
input layer, hidden layers, and output layers. Figure 1 shows an overview of MTDL framework for 
two incomplete modalities.  
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Figure 1. MTDL Framework for Two Incomplete Modalities 
 
 
Amoroso, et al [16] used classification strategy based on Random Forest feature selection and 
Deep Neural Network. Random Forest classifier evaluates the feature importance in terms of mean 
decrease of accuracy and they are the ensembles of tree classifiers which provides a direct multi-class 
model. A standard configuration was adopted with 500 trees and 20 features which was randomly 
selected.Hippocampal volumes was found to be the best performing features and the selected features 
from that was used to train a Deep Neural Network. Feedforward DNN was used, which learned to 
map the feature representation of each patient in the four aforementioned classes. In fact, the 
classification results obtained by DNN allowed the Bari Medical Physics Group (BMPG) to obtain 
one of the most accurate prediction in the participant roaster.  
 
2.3. Deep Convolutional Neural Network 
Jyoti & Zhang [17] have proposed a method which performs four basic operations- convolution, batch 
normalization, and verified linear unit and pooling. They follow a particular connectivity known as 
dense connectivity, where each layer is connected to other layer. Softmax layer is used for 
classification which has four different output classes: nondemented, very mild, mild and moderate 
AD. From the obtained MRI data patches were created and these patches were given as input to the 
proposed network. The size of each patch which used was of the size 112*112 and to handle the 
imbalance in the data set cost sensitive training was used. A cost matrix ξ was used to modify the 
output of the last layer of the network. If o denotes output of the individual model, p denotes the 
desired class and L denotes the loss function, then y denotes the modified output: yi = L(ξp, oi), : yip 
≥ yij∀j 6= p (1) C.H. 
Suh, et al [18] they have used deep learning based automatic brain segmentation and classification 
algorithm for accurate diagnosis of AD. TI-weighted brain MRI images have been used here to a two-
step based DCNN was used to perform brain parcellation followed by 3 classifier techniques 
including XG-Boost for disease prediction. All these classification techniques were performed using 
5-fold cross- validation. XG-Boost method was compared with logistic regression and Support Vector 
Machine by calculating the areas under the curve for differentiating AD from MCI and MCI from 
healthy brain. The conclusion says that TI- weighted brain images are widely available and best for 
prediction of Alzheimer’s Disease.  
 
2.4. Deep Learning with Modified K-Sparse Autoencoder (KSA) 
In Pushkar Bhatkoti, et.al [19] Multiclass Deep Learning Framework with Modified k-sparse 
Autoencoder Classification is proposed which was used to detect Alzheimer disease at early stages. It 
compares the modified approach to non-modified ksparse approach The KSA algorithm is based on 
the learning of representations and performance is attained on categorization tasks. Autoencoders are 
feature extraction algorithms. An autoencoder uses an activation function 𝑦 = 𝑓(𝑃𝑥 + 𝑏) [11]. 
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They used three different inputs (MRI, CSF and PET) and processed them to get the desired 
results. A practical approach with actual MRI images from patient screening was used in the research 
and compared with data from ADNI. The MRI scans were reprocessed by correcting errors and by 
skull strip to obtain the underlying tissues. The images were normalized and smoothened and region 
of interest were obtained and it was used to prepare datasets. Binary classification results in Figure 2 
shows that KSA performed better than the two other previous approaches. The percentages was based 




Figure 2. Cooperative Accuracy Improvement 
 
 
2.5. 3D Convolutional Neural Network 
In Spasov et al [20] Novel deep learning architecture is presented based on dual learning and an ad 
hoc layer for 3D separable convolutions, which aims at identifying those people with MCI who have a 
high risk of developing Alzheimer disease. They combined magnetic resonance imaging (MRI), 
demographic, neuropsychological, and APOe4 genotyping data as input measures where the same 
network layers are used to extract representations from the input biomarkers for both the MCI-to-AD 
conversion task and the AD/HC classification problem.All the analyses were performed on the 
Alzheimer’s Disease Neuroimaging Initiative (ADNI) database and they also combined Tensorflow 
and Keras libraries with their own 3D implementation of 3D separable convolutions. 
 
3. Conclusion 
A complete study was done in different categories on detection of Alzheimer’s disease which 
explained about the methods used, datasets acquired and many more. There were few drawbacks from 
some of the papers like overfitting many parameters where small sets of data had to be used, diagnosis 
is not done at early stage which might lead to risk of the patients life and many more. Currently none 
of the existing methods provide 100% accuracy. In fact new technologies can be used for diagnosis of 
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